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Embryonic and fetal skeletal myoblasts are responsible for the formation of primary and secondary ®bers in mammals, but
the mechanism which diversi®es their fate is unknown. In vitro, embryonic myoblasts are resistant to the differentiation
inhibitory effects of transforming growth factor b and phorbol esters. Thus, differential expression of speci®c molecules
involved in the transduction of extracellular signals may contribute to the different phenotypes. We report here that protein
kinase C u, but none of the other known protein kinase C isoforms, is selectively expressed in fetal and postnatal muscle
cells (at both the myoblast and myotube stage) in vitro and in vivo. By contrast, embryonic myoblasts and myotubes do
not express protein kinase C u in vitro or in vivo. This difference is causally related to a differential response to transforming
growth factor b, since overexpression of protein kinase C u, but not of protein kinase C a or z, in embryonic myoblasts
makes these cells sensitive to transforming growth factor b. These data demonstrate for the ®rst time that a protein kinase
C isoform is a key component of the signal transduction cascade which follows exposure of myoblasts to transforming
growth factor b. They also suggest a speci®c role for protein kinase C u in determining the fate of different myoblasts
during muscle histogenesis. q 1996 Academic Press, Inc.
INTRODUCTION et al., 1992). At this time, satellite cells are ®rst recognized
as a separate myogenic cell type, responsible for postnatal
®ber growth and regeneration (Cossu and Molinaro, 1987;During the histogenesis of murine skeletal muscle, two
Stockdale, 1989; Cossu et al., 1992).classes of myoblasts, respectively termed embryonic and
In vitro studies on muscle cell lines have shown thatfetal, populate the future muscle primordia and give rise
myoblasts proliferate in the presence of mitogens (mainlyasynchronously to primary and secondary muscle ®bers.
®broblast growth factors, FGFs) and differentiate in theirAlthough it has never been formally proven, it is generally
absence (Clegg et al., 1987). However, this simple modelassumed that embryonic myoblasts differentiate into pri-
cannot be applied to developing muscle in vivo where differ-mary ®bers during the embryonic period of development,
entiating and dividing myoblasts coexist within the samewhile fetal myoblasts do not participate in primary ®ber
microenvironment. Recent in situ and organ culture studiesformation and, after a period of active proliferation, differen-
have shown that very high levels of FGF-4 are expressed intiate mainly into secondary ®bers in the fetus (Cossu and
the apical ectodermal ridge (AER) (Niswander and Martin,Molinaro, 1987; Harris et al., 1989; Stockdale, 1989; Cossu
1992; Drucker and Golfarb, 1993) and that FGF-4 can pro-
mote limb bud growth even in the absence of the AER (Nis-
wander and Martin, 1993). These ®ndings suggest that a1 Present address: Department of Cell Biology, Vanderbilt Univer-
sity School of Medicine, Nashville, TN 37232. high concentration of mitogens exists in the distal region
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of the growing limb. This may establish the conditions for 1992; Wetsel et al., 1992). Multiple isoenzymes are often
found in a single cell type (Wetsel et al., 1992; Hug andthe initial formation of primary ®bers at the base of the
limb (where mitogen concentration is likely to be lower). Sarre, 1993). To date, very little is known about substrate
speci®city among the different isoforms, but data are cur-Alternatively, down-regulation of receptors for growth fac-
tors has been proposed as a key event in the initial muscle rently being collected about speci®c biological roles in dif-
ferent systems (Mischak et al., 1993b; Murray et al., 1993;differentiation in the limb (Itoh et al., 1996). Neither of the
two possibilities, however, explains why embryonic myo- Dekker and Parker, 1994; BoucheÂ et al., 1995).
The PKCu is a member of the nPKCs subfamily whichblasts differentiate while fetal myoblasts do not.
Recently, several different observations, reported by is the predominant PKC isoenzyme expressed in skeletal
muscle (Osada et al., 1992; Mischak et al., 1993a). PKCumany laboratories, suggest that transforming growth factor
b (TGFb) may play a regulatory role in skeletal muscle his- expression varies with muscle type (Donnelly et al., 1994)
and innervation (Hilgenberg and Miles, 1995). Although ittogenesis. First, TGFb is abundant in the limb bud; it is
produced by the ectoderm, and it probably acts in a para- is clear that PKCu plays a crucial role in muscle signal
transduction pathways, its mechanism of action is still ob-crine fashion on adjacent mesenchymal cells (Heine et al.,
1987; Lehnert and Akhurst, 1988; Pelton et al., 1989; Millan scure.
In this paper we analyze PKCu expression during limbet al., 1991; Schmid et al., 1991). Second, embryonic myo-
blasts differentiate in the presence of TGFb while fetal myo- muscle development and show that this isoenzyme is ex-
pressed only in fetal muscle (17 days postcoitum, dpc). Fur-blasts do not (Scho®eld and Wolpert, 1990; Cusella-De
Angelis et al., 1994). Finally, treatment of limb bud organ thermore, our results demonstrate that PKCu is involved in
the differential response to TGFb exerted by the differentcultures with anti-TGFb neutralizing antibodies results in
the earlier appearance of large fetal-type myotubes in cul- cell populations of myoblasts.
ture (Cusella-De Angelis et al., 1994). Currently, the molec-
ular mechanisms underlying these phenomena are still un-
clear. It is possible that molecules involved in TGFb signal MATERIALS AND METHODS
transduction are differentially expressed and/or activated in
the two populations of myoblasts. Cell culture. Muscle cells were cultured from limbs of mouse
embryos (11 dpc) or fetuses (16 dpc) as previously described (CossuVery little information is available regarding the TGFb-
et al., 1988). The cells were grown in Dulbecco's minimum essen-induced signaling events. Most studies have been conducted
tial medium (DMEM, Hyclone) supplemented with 10% horse se-in cells where TGFb interferes with cell proliferation. The
rum (HS; Hyclone) and 3% chick embryo extract (EE) for 3 days.signaling mechanisms leading to changes in cell prolifera-
Mouse satellite cells (MSC) were prepared (Cossu et al., 1980, 1983)tion by TGFb are likely to be different, however, in cells
and grown in DMEM supplemented with 20% HS and 5% EE. Tothat are growth stimulated versus those that are growth
induce differentiation, the cells were shifted to DMEM supple-
inhibited. Moreover, the role of TGFb in myoblast differen- mented with 5% HS and 1.25% EE for 3 days. COS1 cells were
tiation is quite different, since it inhibits myogenic differen- obtained from ATCC and cultured in DMEM containing 10% FCS.
tiation without interfering with cell proliferation (Florini At the indicated time, cultures were either ®xed and stained with
et al., 1986; MassagueÁ et al., 1986; Olson et al., 1986). Taken different antisera/antibodies or processed for preparation of cellular
extracts.together, these data indicate that TGFb may be able to acti-
Antisera and antibodies. Several different primary antiseravate different intracellular signaling mechanisms depending
were used in this study. The PKCu antiserum was raised againstupon the status or type of the cell (Mulder and Morris, 1992;
the sequence C332 VPTGKKREPQGISWDSPLDGSNK355 of PKCufor a review see Derynck, 1994).
and puri®ed by af®nity column (Osada et al., 1992). It did not reactOne molecule that is often implicated in these signaling
with any other known PKC isoforms (Osada et al., 1992). The PKCacascades and that appears to mediate different cellular pro-
antiserum was raised against amino acids 313±326 of the human
cesses, such as growth and differentiation, is protein kinase isoenzyme (Boehringer-Mannheim). Antisera to PKCb1, b2 , g, d, e,
C (PKC). PKC constitutes a family of serine/threonine pro- and z (Wetsel et al., 1992; BoucheÂ et al., 1995) and h (W. C. Wetsel,
tein kinases, and, to date, 11 different isoforms have been unpublished) were raised in rabbits against unique amino acid se-
identi®ed and cloned (Nishizuka, 1992). These isoenzymes quences located in the extreme carboxyl terminals of the different
enzymes (Wetsel et al., 1992; BoucheÂ et al., 1995). A monoclonalcan be divided into three major groups: the conventional
antibody (mAb) to the myosin heavy chain (MF20 antibody), whichcalcium- and phospholipid-dependent PKCs (cPKCa, b1, b2,
recognizes all sarcomeric myosins, was used to determine the dif-and g), the novel calcium-independent PKCs (nPKCd, e, h,
ferentiation state of the cells (Bader et al., 1982).and u), and the atypical calcium- and 12-O-tetradecanoyl-
cDNA probes and expression vectors. The SRD plasmids, con-phorbol-13-acetate (TPA)-independent isoforms (z, i/l, and
taining the full-length cDNAs coding for mouse PKCs u (SRDu), a
m) (for a review see Ono et al., 1989; Nishizuka, 1992; Dek-
(YK504), z (M246), and d (M241) under SV40 promoter control, were
ker and Parker, 1994; Johannes et al., 1994). These different used for expression studies (Osada et al., 1992; Mizuno et al., 1991).
isoenzymes have been shown to exhibit differential tissue A 1350-bp fragment obtained by BamHI/EcoRI digestion of the
distribution and cellular localization. While the a, b, d, and SRDu plasmid and a 1000-bp fragment obtained by HindIII digestion
z isoenzymes are ubiquitous, many of the others (e.g., g, h, of the GAPDH plasmid (obtained from ATCC) were used as cDNA
probes.and u) are restricted to one or a few tissues (Osada et al.,
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Preparation of cellular and tissues extracts. Cell pellets were
resuspended in ice-cold homogenization buffer (H-buffer) con-
taining 20 mM Tris (pH 7.5), 2 mM EDTA, 2 mM EGTA, 250 mM
sucrose, 5 mM DTT, 200 mg/ml leupeptin, 10 mg/ml Trasylol, 1
mM PMSF, and 0.1% Triton X-100 and disrupted by sonication.
Total protein extracts were prepared from 13 or 17 dpc mouse em-
bryonic limbs or postnatal muscle. The limbs were removed from
mouse embryos, washed in ice-cold PBS solution, homogenized
in ice-cold H-buffer, and sonicated. Postnatal skeletal muscle was
dissected from the hind limbs of newborn or adult mice; tissues
were homogenized in ice-cold H-buffer and sonicated. The homoge-
FIG. 1. Northern blot analysis of 13 dpc (lane 1) and 17 dpc (lanenate was incubated for 30 min on ice with repeated vortexing and
2) embryo limbs or neonatal (lane 3) and adult (lane 4) skeletalthen centrifuged at 15,000g for 15 min. The pellet was discarded.
muscle. Ten micrograms of poly(A)/ RNA was loaded into eachAn aliquot of the supernatant was used for protein determination
lane and hybridized with the 32P-labeled PKCu cDNA. The 32P-according to the instructions included with the Coomassie Plus
labeled GAPDH cDNA was used for normalization.protein assay reagent (Pierce), while the remainder was used for
Western blot analysis.
Western blot analysis. Total lysates were mixed with 41
Laemmli sample buffer and boiled for 5 min, and 50 mg of each
sample was loaded onto 10% SDS±polyacrylamide gels (Laemmli, RESULTS
1970). The gels were blotted onto nylon ®lter (Hybond-C Extra,
Amersham) and probed with the appropriate speci®c antisera. Per- PKCu Is Differentially Expressed in Embryonic andoxidase-conjugated goat anti-rabbit IgG (Cappel) was used as sec-
Fetal Limb Muscleondary antibody and detection was performed by the ECL method
(Amersham) according to the manufacturer's instructions. To examine the possible role of PKCu in muscle develop-
Immuno¯uorescence analysis. The embryonic or fetal myo- ment and histogenesis, we ®rst analyzed its RNA and pro-
tubes in culture were ®xed 3 days after plating. Proliferating MSC tein expression during skeletal muscle development.
were maintained in growing medium and ®xed after 2 days in cul-
Poly(A)/ RNA was prepared from limb buds of mouse em-ture. MSC-derived myotubes were ®xed after 3 days in culture in
bryos at different stages of development and from postnataldifferentiative medium. Tissue sections were prepared as described
skeletal muscle. Northern blot hybridization was performed(Cusella-De Angelis et al., 1994).
using the PKCu cDNA as a probe (Fig. 1). The accumulationThe cultured cells and the tissue sections were incubated for 1
hr with the anti-PKCu antiserum (diluted 1:100) together with the of the PKCu speci®c message is not detectable in either 13
anti-myosin heavy-chain mAb MF20 (diluted 1:5) (Bader et al., dpc embryo limb buds (Fig. 1, lane 1) or limbs up to 15 dpc
1982). The samples were then incubated for 1 hr with a biotin- (not shown), while it is ®rst evident at 17 dpc in the limb
conjugated goat anti-rabbit IgG (diluted 1:1600, Sigma). Finally, the (Fig. 1, lane 2) and it is maintained at later stages in neonatal
samples were coincubated for 1 hr with ¯uorescein-conjugated goat and adult skeletal muscle (Fig. 1, lanes 3 and 4). It is im-
anti-mouse (diluted 1:200, Cappel), TRITC-conjugated extravidin
portant to stress that mRNA for muscle-speci®c products(diluted 1:200, Sigma), and Oechst. Cultures and slides were
is ®rst detectable by this method between 10 and 12 dpcmounted in Tris (pH 9.00) supplemented with 60% glycerol and
(see for example Barbieri et al., 1990).photographed under an epi¯uorescence Zeiss microscope.
Western blot and immuno¯uorescence analyses con-Northern blot analysis. Total RNA was isolated by the acid
guanidinium±phenol±chloroform method (Chomczynski and Sac- ®rmed the Northern blot data. Total protein lysates were
chi, 1987). Poly(A)/ RNA was isolated from total RNA by oli- prepared from developing and postnatal skeletal muscle, at
go(dT)±cellulose columns (Collaborative Research) (Sambrook et the same stages used for the Northern blot, and examined
al., 1989). Ten micrograms of Poly(A)/ RNA was electrophoresed using the speci®c anti-PKCu antiserum. COS1 cells that
through a 1.2% agarose± formaldehyde gel and transferred to nylon overexpressed PKCu were used as a positive control. The
®lters (Gene Screen Plus, Dupont). The hybridization was per-
anti-PKCu antiserum recognized a single polypeptide whichformed in 50% formamide, 10% dextran sulfate, 11.6 mg/ml NaCl,
migrated with a Mr of approximately 79 1 103 on SDS±0.1 mg/ml denatured salmon sperm DNA, and 1±3 1 106 cpm/ml
PAGE (Fig. 2, lane 1); it does not cross-react with any ofof denatured random-primed 32P-labeled cDNA probes at 427C for
the other PKC isoforms, as already described (Osada et al.,24 hr. The last washing was performed in 0.21 SSC, 0.1% SDS at
557C and the blots were exposed to autoradiography ®lm (Re¯ec- 1992). Western blots from samples taken at different ages
tion, Dupont). revealed that PKCu becomes detectable, by this method,
DNA transfection. Embryonic myoblasts from 11 dpc embryos only in 17 dpc embryos (Fig. 2, lanes 3±5). There was no
were plated in 35-mm tissue culture dishes. Twenty-four hours evidence for PKCu protein expression at earlier stages (Fig.
after plating the cells, at 70% of con¯uence, were transfected with 2, lane 2).
5 mg of DNA by Transfection-reagent (DOTAP; Boehringer-Mann-
These Northern and Western data were further con®rmedheim) for 24 hr. After transfection the cells were cultured for 2
by immunocytochemistry. Immuno¯uorescence analysis ofdays in the absence or presence of 5 ng/ml of TGFb1 or 100 nM
cryosections of limb buds at 13 dpc revealed that the greatTPA (both from Sigma) and ®xed for immuno¯uorescence analysis.
majority of cells showed no immunoreactivity at this stageCOS1 cells were transfected with the SRDu plasmid by electro-
poration as described (Levin et al., 1992). (Fig. 3C). Only a few clusters of cells showed some immuno-
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expression of PKCu is speci®c for fetal and adult myogenic
cells and that it is independent of their differentiation state.
The Ectopic Expression of PKCu in Embryonic
Myoblasts Induces Sensitivity to TGFb
Since PKCs are usually involved in signal transduction,
we examined whether the differential expression of PKCuFIG. 2. Western blot analysis of total protein lysates from 13 dpc
in embryonic and fetal myogenic cells may be causally re-(lane 2) and 17 (lane 3) dpc embryo limbs or neonatal (lane 4) and
lated to their differential sensitivity to extracellular factorsadult (lane 5) skeletal muscle. The blots were incubated with the
af®nity-puri®ed site-speci®c anti-PKCu antiserum. Total protein which interfere with differentiation such as TGFb and phor-
lysate from overexpressing PKCu COS1 cells (lane 1) was used as bol esters. For this purpose we transfected embryonic myo-
positive control. Fifty micrograms of protein lysate was loaded into blasts with an expression vector containing the PKCu full-
each lane. The speci®city of the band was determined by electro- length cDNA and then exposed the transfected cells to
phoretic mobility and competition using an excess of the speci®c TGFb (5 ng/ml) or TPA (100 nM). After 2 days in culture the
immunogen peptide (not shown).
cells were ®xed and the PKCu-overexpressing cells (which
could be easily identi®ed by staining with anti-PKCu antise-
rum) were analyzed for myosin expression under the various
experimental conditions. Overexpression of PKCu did notreactivity and these cells may be precursors of fetal muscle
alter differentiation per se, since roughly the same propor-(see below). However, few myosin-positive primary ®bers
tion of transfected and nontransfected cells differentiatedalso show some immunoreactivity. At 17 dpc a sarcoplas-
under the culture conditions employed (not shown). How-mic ¯uorescence was evident in most of the muscle ®bers
ever, in the presence of either TGFb or TPA, differentiation(Fig. 3D), with smaller secondary ®bers showing stronger
of PKCu-overexpressing cells decreased dramatically to lessstaining. A few groups of ®bers were devoid of immunoreac-
than 10% of controls (Fig. 6). The nontransfected cells weretivity.
not affected by the TGFb or TPA treatment (not shown), inTo investigate whether this late onset of PKCu expression
agreement with previous reports (Cusella-De Angelis et al.,was unique for this isoform, we analyzed the expression
1994). Figure 7 shows an example of a PKCu-overexpressingpatterns of eight additional isoforms (PKC a, b1, b2 , g, d, e,
cell which is not myosin positive in the presence of TGFbz, and h), in embryonic and fetal limb muscle, by Western
(Figs. 7B and 7D) while PKCu-overexpressing cells also ex-blot (Fig. 4). The results showed that PKC g and z are ex-
press skeletal myosin in untreated cultures (Figs. 7A andpressed at both 13 and 17 dpc, while PKC a, b1, b2, and h
7C). Thus, overexpression of PKCu makes embryonic myo-are only expressed at 13 but not 17 dpc. PKC d and e were
blasts sensitive to both TGFb and TPA.not present at either developmental stage. Since PKCu is
Although it appears that PKCu can regulate myoblast di-expressed at 17 dpc and at older ages, it is unique among
versi®cation, it is possible that overexpression of any iso-the isoforms tested, in that it is selectively expressed in
form of PKC would produce these same changes. To testfetal muscle.
this possibility, embryonic myoblasts were transfected with
the expression vectors containing the full-length cDNAs
coding for PKCa, d, and z and then treated with TGFb ex-PKCu Is Not Expressed in Embryonic Myoblasts in
actly as described above. The results (Fig. 6) show that over-Culture
expression of PKCa and z neither inhibits differentiation
per se nor manifests sensitivity to TGFb. Surprisingly, inTo verify whether the differential expression of PKCu dur-
two independent experiments, we did not detect any PKCd-ing limb muscle development could also be detected in dif-
overexpressing cells in either control or treated cultures.ferent myogenic cells, primary cultures of embryonic (from
Figure 7 shows an example of a PKCa-overexpressing cell11 dpc limbs) and fetal (from 16 dpc limbs) myoblasts were
which differentiates in the presence of TGFb (Figs. 7F andanalyzed, both during the proliferative phase and after myo-
7H), as in control cultures (Figs. 7E and 7G). Thus, TGFb-tube formation (Cusella De Angelis et al., 1994). Immuno-
stimulated inhibition of myoblast differentiation correlates¯uorescence analysis shown in Fig. 5 revealed that neither
speci®cally with the presence of PKCu in myogenic cells.embryonic myoblasts nor the myotubes they form in cul-
In contrast, when treated with TPA, PKCa-overexpressingture have detectable levels of PKCu (Figs. 5A and 5D). By
cells do not differentiate (Fig. 6). These data show that morecontrast, both fetal myoblasts and satellite cells express
than one PKC isoform can mediate the TPA inhibitory ef-high levels of PKCu during the proliferative period (Figs. 5B
fect on differentiation. For this reason, it appears that theand 5C). After differentiation, myotubes derived from these
phorbol ester and the TGFb effects on differentiation maycells continue to express PKCu, although at an apparently
lower level (Figs. 5E and 5F). These results indicate that the occur through separate mechanisms.
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FIG. 3. Double-immuno¯uorescence analysis of 10-mm cryosections of 13 dpc (A, C) and 17 dpc (B, D) embryo limbs incubated with the
anti-skeletal myosin monoclonal antibody (mAb) MF20 (A, B) and with anti-PKCu antiserum (C, D). Arrows indicate a cluster of PKCu-
positive cells, which are myosin negative in the 13 dpc embryonic limb. Bar: 10 mm.
FIG. 5. Double-immuno¯uorescence analysis of embryonic (A, D, G) and fetal (B, E, H) myoblasts and satellite cells (C, F, I), under
proliferating (A±C) and differentiating (D±I) conditions, Days 1 and 3, respectively. Fixed cells were incubated with the anti-PKCu
antiserum (A±F) and the anti-skeletal myosin mAb MF20 (G±I). Bar: 10 mm.
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FIG. 4. Western blot using total protein lysates from 13 dpc (lane
2) and 17 dpc (lane 3) embryo limbs, for eight different PKC iso-
forms. Total lysate from brain (lane 1) was used as positive control.
Fifty micrograms of protein lysate was loaded into each lane. The
speci®city of the bands was determined by electrophoretic mobility
and competition using an excess of the speci®c immunogen peptide
(not shown).
FIG. 7. Double-immuno¯uorescence analysis of embryonic limb
cells transfected with the PKCu (A±D) or PKCa (E±H) expression
vectors and cultured in the absence (A, C, E, G) or in the presence
(B, D, F, H) of 5 ng/ml TGFb. The cells were incubated with the
anti-PKCu speci®c antiserum (A, B) or with the anti-PKCa speci®c
antiserum (E, F) and the anti-skeletal myosin mAb MF20 (C, D, G,
H). The single arrow indicates one PKCu-overexpressing embryonic
limb cell which is not myosin-positive in TGFb-treated culture;
two arrows indicate one PKCu-overexpressing myosin-positive em-
bryonic myocyte in untreated culture; arrowheads indicate myosin-
positive embryonic myocytes which are PKCu-negative. Bar: 10
mm.
DISCUSSION
FIG. 6. Effect of TGFb or TPA treatment on differentiation of
embryonic myoblasts overexpressing speci®c PKC isoforms, as in-The data reported in this paper show that the differential
dicated. Primary embryonic limb cell cultures were transiently
sensitivity of embryonic and fetal myoblasts to TGFb is transfected with the speci®c expression plasmids, in the absence
dependent upon selective expression of the u isoform of (C) or in the presence of TGFb (5 ng/ml) or TPA (100 nM), as
protein kinase C. This is the ®rst evidence showing that indicated. After 2 days in culture, the percentage of nuclei of PKC-
the expression of a molecule involved in signal transduction overexpressing cells which coexpress skeletal myosin was deter-
mined under each condition.is causally related to the phenotypic difference among dif-
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ferent populations of myogenic cells. We suggest that this otubes. Thus far, unavailability of speci®c antibodies has
precluded the single cell analysis, which is necessary givenphenotypic difference is essential for asynchronous genera-
tion of muscle ®bers during embryogenesis. Our data also that embryonic and fetal primary myogenic cells cannot be
selected after transfection.show that the u isoform of PKC is a downstream target
in postreceptorial signaling induced by TGFb in myogenic Why differential expression of PKCu should dictate the
differential fate of embryonic versus fetal myoblasts re-cells.
PKCu has been initially identi®ed as a muscle-speci®c mains, at present, a matter of speculation. It is a fact, how-
ever, that only a fraction of the total myogenic precursorisoform (Osada et al., 1992). While subsequent studies have
demonstrated its presence in other tissues (Wang et al., population differentiates in the embryo to give rise to pri-
mary ®bers. A possible mechanism to ensure that certain1993), PKCu is the most abundant PKC isoform to be ex-
pressed in adult skeletal muscle. The data reported in this myoblasts will differentiate in an environment which is
permissive for proliferation may be based on unrespon-paper show that PKCu is also expressed in neonatal and
fetal but not in embryonic muscle in vivo. In addition, cul- siveness of these myoblasts to growth factors and/or to mol-
ecules which inhibit differentiation. A long search forture studies reveal that PKCu is selectively expressed by
fetal myoblasts, which in vivo populate the developing limb growth factors which may affect selectively proliferation
of fetal versus embryonic cells failed to yield any possibleand body wall. No other PKC isoform, among those we have
tested, shows the same pattern of expression. Indeed, no candidate molecule for such a role. Recently, loss of ®bro-
blast growth factor receptor has been proposed as a possibleother isoform of enzymes involved in signal transduction
is known to be expressed in fetal but not in embryonic mechanism to control myoblast differentiation in vivo (Itoh
et al., 1996). However, this does not explain why certainmyogenic cells. This fact raises the possibility that such
differential expression may be functionally relevant to mus- myoblasts differentiate and others do not. On the other
hand, TGFb became an obvious candidate for this role whencle histogenesis. Embryonic myoblasts, which do not ex-
press PKCu, differentiate in the presence of TGFb or TPA, it was shown that it can inhibit differentiation of fetal but
not of embryonic cells (Cusella-De Angelis et al., 1994).an activator of certain PKC isoforms (cPKC and nPKC).
However, when PKCu is overexpressed in embryonic mus- Furthermore, the limb bud contains high levels of TGFb in
the place and at the time when differentiation of embryoniccle cells, they become responsive to TGFb and to TPA.
PKCu appears to speci®cally provide the sensitivity to myoblasts occurs (Millan et al., 1991; Schmid et al., 1991).
It is worth noting that muscle differentiation begins in theTGFb, since overexpression of two different isoforms,
PKCa and z, is not effective. These latter data exclude the proximal region of the limb. This is the region most distant
from the apical ridge, which produces FGFs (Niswander andpossibility that the observed PKCu effect can be mimicked
by overexpression of any PKC isoform, which may alter the Martin, 1992; Drucker and Golfarb, 1993). Therefore, al-
though the actual concentration of any single FGF in thisdelicate balance among the various isoforms, and thereby
lead to a nonspeci®c response to extracellular signaling. region is very dif®cult to measure, it is conceivable that all
myoblasts in this area may be exposed to a low growthA different situation arises for the TPA-responsive path-
way. Overexpression of PKCa was as effective as PKCu in factor concentration (or may down-regulate receptors) but
to a high concentration of TGFb. At this time, embryonicinducing sensitivity of embryonic myoblasts to TPA. Since
most of the PKCs (classical and novel) are known to be myoblasts, which do not express PKCu and, thus, are insen-
sitive to TGFb, may differentiate into primary ®bers, whiledirect targets for TPA, this result suggests that these differ-
ent activated PKCs may serve to conjointly orchestrate dif- differentiation of fetal myoblasts, which do express PKCu,
should be prevented by TGFb. Once primary ®bers areferentiation in the myoblast. Whether these same condi-
tions would be encountered in the normal physiological formed, they begin to produce growth factors such as FGF
(Drucker and Golfarb, 1993) and, thus, promote a new wavestate is unclear. Nonetheless, our data indicate that the
TGFb signaling pathways are speci®cally mediated by PKCu of proliferation in fetal cells (De Angelis et al., 1992). Fur-
thermore, this hypothesis requires that when fetal myo-in myogenic cells. This hypothesis is also reinforced by the
observation that different myogenic populations do not re- blasts differentiate, they either become resistant to TGFb
(e.g., PKCu negative) or the actual concentration of the vari-spond similarly to both factors. For example, satellite cells
express a high level of PKCu and are sensitive to TGFb ous TGFbs decreases signi®cantly. The ®rst possibility is
ruled out by our present data showing that primary ®bers,(Allen and Boxhorn, 1987); however, these cells are not re-
sponsive to TPA (Cossu et al., 1983). after formation, begin to express PKCu, while both fetal
myoblasts and the secondary ®bers they form express PKCu.Embryonic and fetal myoblasts give rise in vitro, and
probably in vivo, to myotubes which express different mus- The second possibility is, rather, more likely, since our un-
published results show a dramatic decrease in the level ofcle-speci®c gene products, such as slow myosin heavy
chain, muscle creatine kinase, and b-enolase (Barbieri et al., TGFb1 message, just at the onset of fetal myoblast differen-
tiation.1990; Cusella-De Angelis et al., 1994). It would be interest-
ing, therefore, to know whether differential expression of The identi®cation of PKCu as a key component of this
pathway permits the design of experiments where expres-PKCu is responsible for both differential sensitivity to TGFb
and differential gene expression in fetal and embryonic my- sion of this enzyme in vivo, driven by the promoter of genes
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Cusella-De Angelis, M. G., Molinari, S., Le Donne, A., Coletta, M.,expressed early in the limb bud, should provide each cell
Vivarelli, E., BoucheÂ , M., Molinaro, M., Ferrari, S., and Cossu,with PKCu. If the prediction is correct, all myogenic cells
G. (1994). Differential response of embryonic and fetal myoblastsshould become sensitive to TGFb, and primary ®bers
to TGFb: A possible regulatory mechanism of skeletal muscleshould not be formed in the mouse developing limbs. This
histogenesis. Development 120, 925 ±933.possibility is currently under investigation.
De Angelis, L., Cusella-De Angelis, M. G., BoucheÂ , M., Vivarelli,
E., Boitani, C., Molinaro, M., and Cossu, G. (1992). ACTH-like
peptides in postimplantation mouse embryos: A possible role in
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